Top Markets
Coin of the day
GeneFerm Biotechnology Co., Ltd. GeneFerm Biotechnology Co., Ltd.

GeneFerm Biotechnology Co., Ltd.

1796
Peringkat dalam Saham #26677
GeneFerm Biotechnology Co., Ltd. specializes in the development, production,... GeneFerm Biotechnology Co., Ltd. specializes in the development, production, and global distribution of fermented health and wellness products, serving both the Taiwanese domestic market and international clients. The company's extensive product line includes a variety of microbial fermentation offerings such as different types of mushrooms, lactic acid bacteria, other bacterial strains, yeast, and algae. Furthermore, GeneFerm provides a wide array of bio-fermented ingredients, including specialized powders like nattomena, natto fermented powder, red yeast rice fermented powder, and various mycelial powders (e.g., antrodia cinnamomea, cordyceps, reishi, phellinus linteus, armillaria mellea). They also supply beta-glucan powder, fermented fruit and vegetable enzymes, as well as probiotic and peptide components. Beyond its product sales, GeneFerm offers additional services such as private label supplement manufacturing, packaging equipment, and expert microbial fermentation toll manufacturing and consulting. Established in 1988, the company maintains its headquarters in Tainan City, Taiwan.
Harga Saham
$0.93330147
Kapitalisasi Pasar
$38.69M
Perubahan (1 hari)
-1.01%
Perubahan (1 tahun)
-39.84%
Negara
TW
Perdagangan GeneFerm Biotechnology Co., Ltd. (1796)

Kategori

Laba untuk GeneFerm Biotechnology Co., Ltd. (1796)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari GeneFerm Biotechnology Co., Ltd., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk GeneFerm Biotechnology Co., Ltd. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing